PPT-Workshop on IP & Access to Medicines at

Cochin University of Science amp Technology Sakthivel Selvaraj Public Health Foundation of India New Delhi shaktiphfiorg Access to Medicines in India Key Barriers to Access to Medicines . Zambia Civil Society Consultation Meeting. 1. st. October 2013 . Daniel S. . Libati. , LLB (UNZA) . CSO Consultant. Basis of CSO work?. When one speaks of civil society and its work with regards to engaging government, the first question that has to be settled before such engagement takes place is with regards to the ‘BASIS’ of such engagement.. for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Gilles Forte. Policy. , Access and Use Team. Department for Essential . Medicines and Health Products. World Health Assembly Resolution 67.22 . Access . to essential medicines. Recognize . the importance of effective national medicines policies, and their . Gilles . Forte. Coordinator, Policy, Access and Use Team. Essential . Medicines . and . Health Products. . WHO . mandate . within the . International . Drug Control Conventions. 1961 . Single Convention on Narcotic Drugs (Article 3). WHO EMP and NVI Departments. Access to NCD essential medicines . on the global agenda. Access to chronic disease medicines is required for the fulfilment of MDG8. Governments, in collaboration with the private sector, should give greater priority to treating chronic diseases and improving the accessibility of medicines to treat them (MDG Report 2009). 30 June 2016. Presentation Outline . Programme Background. Problem Statement & Approach. SMD and PPN platforms . Sustainability. Q & A . . Programme overview. Initiated as a support programme for the SADC Pharmaceutical Business Plan, through the Department for International Development (DFID-UK) between 2009 and 2014, and now continues to operate as a regional programme through engagement with various partners and facilitators in the public and private sectors. Kathy Maxwell. Community Pharmacist. Hillpark. Care Chemist, . Manurewa. Pharmacist’s Role. Pharmacists are the . scientist. , the . medicine adviser. , the . clinical practitioner. , the . social carer. The . HDA (formerly BAPW) . Who we are. Good Distribution Practice . HDA is a UK-wide representative trade association whose mission is to advance the interests and values of those member companies who provide . Medicines Manufacturing in the UK 2017. Welcome by Andy Evans. Chair, MMIP. Site Lead, AZ Macclesfield. Morning Agenda. 10:00. Introduction. Steve. Thompson ABPI. Steve Bates BIA. Sue Dunkerton KTN. 2018. Objectives. Prescribing & Zero tolerance. National Alerts . Medicines Reconciliation. Policies. Pharmacy Services . . . “The General Medical Council (GMC) states that . all. doctors must keep . how . the pandemic has influenced the disease burden. Bengt . Jönsson. Professor emeritus, Stockholm School of Economics. Wednesday, 1 July 2020 – 16.30-19.00 CET (online event. ). Launch of the European Parliament  . Dr. Richard Torbett. Chief Economist, EFPIA. China/ EU Pharmaceutical Industry Forum. Shanghai, . 16 May 2015. Policy debate on health in recent years has been dominated by cost containment. Health & Growth.